首页> 外文期刊>Electronic Physician >Effect of adding dexamethasone to lidocaine on the quality of intravenous regional anesthesia for upper extremity orthopedic operations: A randomized clinical trial
【24h】

Effect of adding dexamethasone to lidocaine on the quality of intravenous regional anesthesia for upper extremity orthopedic operations: A randomized clinical trial

机译:利多卡因中添加地塞米松对上肢骨科手术静脉区域麻醉质量的影响:一项随机临床试验

获取原文
           

摘要

Background Intravenous regional anesthesia (IVRA) is an ideal technique for short surgery on the distal extremities. Different additives have been used to improve lidocaine’s block quality. Objective The aim of this study was to determine the effect of adding dexamethasone to lidocaine on improving the quality of IVRA. Methods This study is a prospective, double-blind randomized study which was done on patients with upper extremity injuries of the distal elbow in Shahid Mohammadi Hospital, Bandar Abbas from October 2014 to December 2015. A total of 110 patients aged 15 to 65 years, with ASA class I and II, with orthopedic injuries distal to the elbow, were randomly divided into two groups. The control group (L) and the intervention group (L+D) received a 40-ml solution of 3 mg/kg lidocaine, and 3 mg/kg lidocaine + 8 mg of dexamethasone respectively. The two groups were compared in terms of onset and recovery time of sensory block in each of the dermatome nerves classified as radial, ulnar, and median, vital signs, patient satisfaction, intraoperative opioid consumption, and request for the first postoperative opioid. Results There was no significant difference between the two groups in terms of demographic characteristics. Mean arterial blood pressure was higher in the L + D group (100.39±14.6 mmHg) in comparison to the L group (90.50±11 mmHg) (p=0.002). Need for opioid was reported in 20 (35.7%) patients in the L + D group in comparison to 17 (31.5%) in the L group (p=0.639). The average intraoperative dose of fentanyl was 95±32.04 mcg and 88.44±18.77 mg in L + D and L groups respectively and there was no significant difference between the two groups in this respect (p=0.479). In addition, the average dose of pethidine administered in the recovery room for L + D group (19.34±15.22) mg was significantly higher than in the L group (9.44±12.26 mg) (p=0.001). Conclusions Adding 8 mg dexamethasone to lidocaine has no effect on IVRA solution in upper extremity orthopedic operations and also increases postoperative opioid consumption. Trial registration The trial was registered at the Iranian Registry of Clinical Trials ( http://www.irct.ir ) with the Irct ID: IRCT2016052928158N1. Funding The authors received financial support from Hormozgan University of Medical Sciences.
机译:背景技术静脉区域麻醉(IVRA)是远端肢体短手术的理想技术。已经使用了不同的添加剂来改善利多卡因的阻滞质量。目的本研究的目的是确定在利多卡因中添加地塞米松对改善IVRA质量的作用。方法该研究是一项前瞻性,双盲随机研究,于2014年10月至2015年12月在阿巴斯港的Shahid Mohammadi医院对远端肘关节上肢损伤的患者进行。共110例患者,年龄15至65岁, ASA I级和II级,肘部远端骨科损伤的患者被随机分为两组。对照组(L)和干预组(L + D)分别接受40 ml的3 mg / kg利多卡因溶液和3 mg / kg利多卡因+ 8 mg地塞米松溶液。比较两组患者的感觉,分别以radial骨,尺骨和中位,生命体征,患者满意度,术中阿片类药物的消耗量以及术后首次使用阿片类药物的感觉为出发点。结果两组在人口统计学特征上无显着差异。与L组(90.50±11 mmHg)相比,L + D组(100.39±14.6 mmHg)的平均动脉压更高(p = 0.002)。 L + D组有20名(35.7%)患者需要阿片类药物,而L组则为17名(31.5%)(p = 0.639)。 L + D组和L组的平均术中芬太尼剂量分别为95±32.04 mcg和88.44±18.77 mg,在这方面,两组之间无显着差异(p = 0.479)。此外,L + D组在恢复室中给予的哌替啶的平均剂量(19.34±15.22)mg明显高于L组(9.44±12.26 mg)(p = 0.001)。结论在利多卡因中添加8 mg地塞米松对上肢整形外科手术中的IVRA溶液无影响,并且增加了术后阿片类药物的消耗。试验注册该试验已在伊朗临床试验注册处(http://www.irct.ir)进行了注册,其Irct ID:IRCT2016052928158N1。资金作者从霍莫兹根医科大学获得了财政支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号